DNA Script
NEWS
Life sciences and biopharma companies strengthen their leadership teams and boards with these Movers & Shakers.
Here’s who rang in the New Year by joining the NASDAQ or raising private equity funds.
DNA Script announced it secured a $200 million Series C financing, bringing the total amount raised by the biotech company to $315 million since its founding in 2014.
While the volatility of the market has some shying away from going public, private investment dollars are still rolling in each week. Check out our top picks.
GE Research selected DNA Script to join a collaboration working on a rapid response, mobile platform to develop on-demand production of nucleic acid-based vaccines and therapies related to biological threats.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
IN THE PRESS
JOBS